Drug class
Fluconazole prodrug; triazole antifungal
Mechanism of action
Fosfluconazole is hydrolysed to fluconazole, which inhibits fungal lanosterol 14-alpha-demethylase (CYP51), impairing ergosterol biosynthesis and fungal cell-membrane formation.
General use cases
- Intravenous antifungal treatment or step-down therapy for systemic fungal infections susceptible to fluconazole where fosfluconazole formulations are authorised; exact indications depend on product and jurisdiction
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
